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Prosthetic joint infection (PJI) after total ankle replacement (TAR) is a challenging complication, 
which often requires debridement and implant retention (DAIR) with or without polyethylene 
exchange; revision surgery; implantation of a cement spacer; conversion to arthrodesis; or even 
amputation. The optimum treatment for ankle PJI is not well established. We conducted a systematic 
review and meta-analysis to compare the clinical effectiveness of various treatment strategies for 
infected ankle prostheses. We searched MEDLINE, Embase, Web of Science, and The Cochrane 
Library up to December 2018 for studies evaluating the impact of treatment in patient populations 
with infected ankle prostheses following TAR. Binary data were pooled after arcsine transformation. 
Six citations comprising of 17 observational design comparisons were included. The re-infection rates 
(95% CIs) for DAIR with or without polyethylene exchange, one-stage revision, two-stage revision, 
cement spacer, and arthrodesis were 39.8% (24.4-56.1), 0.0% (0.0-78.7), 0.0% (0.0-8.5), 0.2% (0.0-
17.9) and 13.6% (0.0-45.8) respectively. Rates of amputation for DAIR with or without polyethylene 
exchange and cement spacer were 5.6% (0.0-16.9) and 22.2% (6.3-54.7) respectively. Measures of 
function, pain, and satisfaction could not be compared because of limited data. One- and two-stage 
revision strategies seem to be associated with the lowest re-infection rates, but these findings are 
based on limited data. Arthrodesis and DAIR with or without polyethylene exchange appear to be 
commonly used in treating infected ankle prosthesis, but are associated with poor infection control. 
Clear gaps exist in the literature and further research is warranted to evaluate treatment strategies for 
infected ankle prosthesis. 
 
Level of evidence: 3 
 






Fusion or arthrodesis has long been the widely accepted treatment for end-stage osteoarthritis of 
the ankle. However, with the emergence of third generation three component mobile-bearing implants 
(1, 2), total ankle replacement (TAR) has become popular and recognised as an equally effective 
alternative (3, 4). Compared to hip and knee replacements, relatively few ankle replacements are 
performed. In 2017, approximately 100,000 joint replacements were performed each in knees and hips 
as recorded in the National Joint Registry for England, Wales and Northern Ireland and the Isle of 
Man; whereas only 734 ankle replacements were performed (5). Prosthetic joint infection (PJI) is a 
potentially devastating, albeit uncommon complication of TAR which results in implant failure (6). 
The incidence of ankle PJI has been reported to range between 1.1% and 8.9% (4, 7, 8), which exceed 
rates for hip or knee replacement (9). The soft tissue envelope of the ankle joint makes the 
management of PJI following TAR challenging. Like other joints, the goals of PJI treatment are to 
eradicate infection, provide substantial pain relief, maintain or restore joint function, and to improve 
quality of life (10). Several treatment options for ankle PJI exist including long-term suppressive 
antibiotic treatment without surgical intervention; debridement and implant retention (DAIR) with or 
without polyethylene exchange; one-stage revision surgery; two-stage revision surgery; prosthesis 
component removal and implantation of a cement spacer; arthrodesis; and amputation. Below-knee 
amputation is considered as a last resort after other limb salvage procedures have failed. Though the 
choice of an appropriate treatment depends on factors which include the timing and the type of 
infection, the standard treatment strategy for an infected ankle prosthesis is not well defined. 
Treatment options have generally been based on surgeons’ preferences and experiences as well as 
evidence from hip and knee replacement data. Unlike hip, knee, and shoulder joints, where there is an 
extensive body of evidence showing the clinical effectiveness of the one- and two-stage revision 
strategies for managing PJI of these joints (11-14), this is not so for infected ankle joints. Published 






To bring the existing evidence together, we conducted a systematic review and meta-analysis to 
compare the clinical effectiveness of the following treatment strategies for the management of PJI 
following TAR using infection control as a primary outcome: long-term suppressive antibiotic 
treatment without surgical intervention; debridement, treatment with antibiotics and retention of the 
prosthesis (DAIR) with or without polyethylene exchange; one-stage revision surgery; two-stage 
revision surgery; prosthesis component removal and implantation of cement spacer; and arthrodesis. 
Our secondary objectives included (i) comparing the clinical effectiveness of the above treatment 
strategies using measures of pain, function, and satisfaction; non-infection related adverse events; 
conversion to arthrodesis; and amputation and (ii) to identify gaps in the evidence and areas for future 
research. 
 
Materials and Methods 
Data Sources, Search Strategy and Screening 
This review was registered in the PROSPERO prospective register of systematic reviews 
(CRD42018119102) and followed PRISMA and MOOSE guidelines (15, 16) (Appendix 1-2). We 
conducted a systematic electronic search in the following databases from inception to 09 December 
2018: MEDLINE, Embase, and The Cochrane library.  We constructed the search strategy by 
combining key words related to the population and outcomes, with no limits on language. Details of 
the search strategy are reported in Appendix 3. All titles and abstracts of studies retrieved from the 
databases were screened to assess their suitability for inclusion. One reviewer (SKK) initially 
screened all titles and abstracts for potentially eligible papers and subsequently acquired full text 
papers. Full text evaluation was conducted by two independent reviewers (SKK and MCB) against the 
eligibility criteria. Any discrepancies were discussed and the opinion of a third reviewer (MRW) was 
sought when necessary to achieve consensus. The “cited by” function in Web of Science and the 
reference lists of included studies and review articles were manually assessed to identify any relevant 






We included papers that (i) evaluated the clinical impact of the following strategies: long-term 
suppressive antibiotic treatment without surgical intervention; DAIR with or without polyethylene 
exchange; one-stage revision surgery; two-stage revision surgery; prosthesis component removal and 
implantation of cement spacer; and arthrodesis in a longitudinal observational study or randomized 
controlled trial (RCT) in patient populations with infected ankle prostheses following TAR and (ii) 
were followed post-operatively for re-infection (defined as recurrence of infection by the same 
organism(s) and/or re-infection with a new organism(s)); and/or other clinical outcomes including (a) 
function, pain, or satisfaction as measured by patient-reported outcomes such as the American 
Orthopaedic Foot & Ankle Society (AOFAS) hindfoot score, Short Form–36 (SF-36), visual analog 
scale (VAS), Short Musculoskeletal Function Assessment (SMFA), Foot and Ankle Outcomes Score 
(FAOS), and American Orthopaedic Foot and Ankle Society score (AOFAS); (b) non-infection 
related complications (such as implant failure, fracture, re-operation, non-union, loosening, 
haematoma, postoperative instability); (c) conversion from one of the interventions above to 
arthrodesis; or (d) conversion from one of the interventions above to amputation. 
 
Data Extraction and Quality Assessment 
Using a standardized data extraction form in Microsoft Excel, one reviewer (SKK) independently 
extracted qualitative and quantitative information from included papers on study design, patient 
characteristics, nature of interventions, and outcomes. A second reviewer (MCB) independently 
checked these extracted data with that in the original papers. Discrepancies between the two data 
extractors (SKK and MCB) were discussed, and the opinion of a third reviewer (MRW) was sought if 
necessary to achieve consensus. When insufficient data were reported in available papers, we 
contacted authors to provide further information. We assessed the methodological quality of included 
studies using the Methodological Index for Non-Randomised Studies (MINORS), a validated 





studies from 0-16 using eight pre-defined domains namely: a clearly stated aim, inclusion of 
consecutive patients, prospective collection of data, endpoints appropriate to the aim of the study, 
unbiased assessment of the study endpoint, follow-up period appropriate to the aim of the study, loss 
to follow-up less than 5%, and prospective calculation of the study size. For each item, the instrument 




For binary data, rates with 95% confidence intervals (CIs) were used as summary measures across 
studies and these were estimated using the Freeman-Tukey variance stabilising double arcsine 
transformation (18). The primary outcome, which was the rate of re-infection, was estimated for each 
treatment strategy by dividing the number of re-infections within the follow-up period following 
treatment or revision surgery for infected ankle prostheses by the total number of participants with PJI 
or number of infected ankle joints. Corresponding rates (with 95% CIs) of non-infection related 
adverse events, conversion to arthrodesis, and amputation were also estimated. It was planned to 
compare clinical measures of function, pain, and satisfaction between the treatment strategies using 
descriptive statistics, but this could not be done because of limited data. Stata version 15 (Stata Corp, 
College Station, Texas, USA) was used for all statistical analyses.  
 
Results 
Study Identification and Selection 
A total of 728 citations were retrieved from the search and of this number, 717 (98.5%) citations 
were excluded based on titles and abstracts. On reviewing the full texts of the remaining 11 (1.5%) 
articles, we excluded 5 articles because (i) the population was not relevant (n=3) and (ii) intervention 






Study Characteristics and Study Quality 
Table 1 provides details on individual baseline characteristics and methodological quality of 
individual studies by treatment strategy for infected ankle prostheses. The 6 eligible articles 
comprised of 17 unique studies or comparisons based on treatment strategies utilized: 4 studies on 
DAIR with or without polyethylene exchange; 2 studies on one-stage revision surgery; 2 studies on 
two-stage revision surgery; 3 studies on prosthesis component removal and implantation of antibiotic-
loaded cement spacer; and 4 studies on arthrodesis. Overall, there were 105 participants or infected 
ankle prostheses and 11 re-infections. All included studies were based on retrospective data analyses 
of observational cohort designs or case series. No RCTs comparing treatment strategies were 
identified. Studies were carried out in Europe (UK and Switzerland) and North America (United 
States of America). The methodological quality scores of included studies ranged from 8-11.  
 
Treatment Strategies and Infection Control 
Fig. 2 reports the rates of re-infection for the various treatment strategies. In pooled analysis of 
three studies reporting relevant data, the re-infection rate for DAIR with or without polyethylene 
exchange was 39.8% (95% CI: 24.4-56.1). The rates for one- and two-stage revision surgeries were 
0.0% (95% CI: 0.0-78.7) and 0.0% (95% CI:0.0-8.5) respectively. That for antibiotic-loaded cement 
spacer and arthrodesis as a primary treatment were 0.2% (95% CI: 0.0-17.9) and 13.6% (95% CI: 0.0-
45.8) respectively.  
 
Treatment Strategies and Other Post-operative Clinical Outcomes 
DAIR with or without polyethylene Rates of conversion to arthrodesis and amputation were 18.9% 
(95% CI: 6.6-34.3) and 5.6% (95% CI: 0.0-16.9) respectively. In one study that reported on 
satisfaction outcomes, all 14 patients who were infection free after the treatment were satisfied with 
their outcomes.(20) In another study that reported on patient-reported measures of function, pain, and 





Bother, SF-36 Physical, and AOFAS Hindfoot scores when postoperative PJI treatment scores were 
compared with preoperative primary TAR scores.(24) 
Implantation of antibiotic-loaded cement spacer Rates of non-infection related adverse events and 
amputation were 18.6% (95% CI: 1.9-43.2) and 22.2% (95% CI: 6.3-54.7) respectively. In one study 
of 9 patients, all 7 patients who retained their spacer insitu were able to mobilize with full weight 
bearing, had no or experienced occasional mild pain, and were satisfied with their outcomes.(19) 
Arthrodesis Four studies reported on arthrodesis as a primary treatment for infected ankle 
prosthesis. None of the studies reported on any non-infection related adverse events. One study 
reported on a series of 6 patients, of which 3 patients failed to have their infection cleared and 
therefore required below knee amputation (22). 
No studies reported on mortality outcomes and none of the one- or two-stage revision studies reported 
on complications, conversion to arthrodesis, or amputations following revision arthroplasty.  
 
Discussion 
Compared to infected total knee and hip replacements, the standard treatment strategy of infected 
ankle prostheses is not well defined. We have attempted to compare the clinical effectiveness of 
several treatment strategies for infected ankle prosthesis using a literature-based systematic meta-
analysis. Treatment strategies were compared using infection control as a primary outcome and other 
clinical measures such as pain, function, satisfaction, non-infection related adverse events, 
conversion to arthrodesis, and amputation. Based on the limited data available, one- and two-stage 
revision strategies were associated with the lowest re-infection rates. A high re-infection rate was 
observed for DAIR with or without polyethylene exchange, followed by arthrodesis. DAIR with or 
without polyethylene exchange and use of a cement spacer were also associated with moderately high 
rates of conversion to arthrodesis and amputation respectively. No complications, conversion to 
arthrodesis, or amputations were reported by any of the one- or two-stage revision studies. Measures 





did not report this data.  
Data on treatment strategies for infected ankle prostheses is very limited and hence it is 
challenging to make any evidence-based conclusions on which treatment strategy is more clinically 
effective. However, it does appear that the one- and two-stage revision rates are associated with the 
lowest re-infection rates. Furthermore, published studies do not report any non-infection related 
adverse events related to these strategies. These findings are not surprising given that these two 
treatment strategies are the obvious choices for the treatment of chronic PJI in other joints such as the 
hips, knees, and shoulders (11-14). This review has also identified substantial gaps in the existent 
literature; though TARs are associated with higher incidence of PJIs compared with hip or knee 
replacements (25-27), there is a general lack of evidence on the optimal treatment strategies for 
managing infected ankle joint replacements. Of the over 700 retrieved citations, only 6 published 
articles were found to be relevant to the topic. Given the extensive body of published evidence on PJI 
treatment in hip and knee joints, it is puzzling that only a handful of studies have been published on 
the management of infected ankle prostheses. It is likely that the paucity of data on treatment of ankle 
PJI is due to the lower incidence of TAR utilization. For example, whereas about 100,000 joint 
replacements were performed each in knees and hips in England, Wales and Northern Ireland and the 
Isle of Man in 2017, only about 700 ankle replacements were performed that same year (5). Though 
there is clear evidence from other joints such as the hips, knees, or shoulders that the two-stage 
revision is the standard treatment for PJI, the current findings suggest that arthrodesis as a primary 
treatment and DAIR with or without polyethylene exchange are more commonly used in treating 
infected ankle prosthesis. This is likely to be due to arthrodesis being an accepted and commonly 
used treatment for the degenerative ankle, which is not the case for the hip and knee, and the 
challenge of surgical reconstruction of the ankle in terms of bone stock and soft tissues if more 
invasive revision strategies are employed. Although DAIR with or without polyethylene exchange is 
associated with acceptable infection control rates in other joints, it is more beneficial in the early 





DAIR with or without polyethylene in the ankle is associated with low infection control rates in 
comparison to other joints. Indeed, DAIR with or without polyethylene has been reported to have 
high rates of failure when used for treating PJI following TAR (29). Arthrodesis as a primary 
treatment for infected ankle prosthesis is considered to be a salvage procedure, but as range of 
motion of the ankle joint is of lower concern to patients with an infected joint replacement than it is 
in the hip or knee, it is more acceptable. Performing arthrodesis in a previously replaced ankle is 
challenging due to poor bone stock and involves prolonged surgical and medical treatment with 
multidisciplinary teams (30). The one- and two-stage revision strategies are commonly associated 
with high infection control rates in lower limb replacement (11, 12) and shoulder arthroplasty (13), 
but their role in treating infected ankle prosthesis seems less established particularly in the case of 
one-stage revision where only two cases were reported. Given the limited data available, it appears 
orthopaedic surgeons must apply treatment principles from infected hip and knee replacements to 
infected ankle prostheses. Infections following TAR seem to run a completely different clinical 
course compared to that of other joints; the majority of cases of PJI of the ankles seem to originate 
from exogenous sources, infection is difficult to diagnose and requires a high index of suspicion, and 
there seems to be no consensus on the definition of PJI following TAR (29). It is thus possible that 
the principles of PJI treatment in other joints may not apply to that of ankles. The overall societal 
cost of PJI is high and the experience of managing infected ankle replacements is more limited due to 
the lower number of cases, hence we encourage units with experience of the management of infected 
ankle replacements to report their results and add to the evidence base. 
The evidence on the topic is scanty and sparse, hence the need for a systematic review to bring the 
evidence together and identify any gaps in the literature. This study represents the first attempt to 
achieve this. Our search was comprehensive and it spanned several databases including “cited by” 
search in Web of Science, with manual reference scanning. Although outcome data was limited, our 
data extraction was thorough which enabled some pooling to enhance interpretation of findings. We 





detailed assessment of the methodological quality of the included studies using a validated tool. There 
were limitations to the review which were mostly inherent to the included studies. A head-to-head 
comparison of the clinical effectiveness of the treatment strategies evaluated could not be robustly 
done because of the limited number of studies, small sample sizes, and selective reporting of 
outcomes. Attempts to get investigators of these studies to contribute missing data did not yield any 
results.  
In conclusion, one- and two-stage revision strategies seem to be associated with the lowest re-
infection rates, but these are based on very limited data. Arthrodesis and DAIR with or without 
polyethylene exchange appear to be commonly used in treating infected ankle prosthesis, but these 
are associated with relatively low infection control rates. The current findings are timely and relevant 
because they provide insight on the large gaps in the existing literature. Further investigation is 
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Figure 1 PRISMA flow diagram 
728 Potentially relevant citations identified
From MEDLINE, EMBASE, Web of Science, 
Cochrane Library, and reference list of 
relevant studies
717 excluded on the basis of title 
and/ or abstract
5 Articles excluded due to:
3 Population not relevant
2 Intervention not relevant
6 Articles included, based on 17 
studies/comparisons
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Table 1. Baseline characteristics of individual studies included in review 
Lead author, 
publication date 




























DAIR with or without polyethylene exchange 
Kessler, 2014 Switzerland 2006-2011 62.1* 14.0* 2.6* 7 NR 3 1 21 NR NR 14 patients who were 
infection free had 
satisfactory function 
11 
Myerson, 2014 USA 2002-2011 65.5* 58* 2.2* 4 NR 1 NR 4 NR NR NR 10 
Patton, 2015 USA 1995-2012 54.5* 53* 4.6* 0 NR NR NR 5 NR NR NR 8 








FAOS Pain score 
comparable to pre-
intervention score 
SF-36 Mental and Bother 
were comparable to pre-
intervention scores 
11 
One-stage revision surgery 
Kessler, 2014 Switzerland 2006-2011 62.1* 14.0* 2.6* 0 NR NR NR 1 NR NR NR 11 
Patton, 2015 USA 1995-2012 78 0 4.6* 0 NR NR NR 1 NR NR NR 8 
Two-stage revision surgery 
Kessler, 2014 Switzerland 2006-2011 62.1* 14.0* 2.6* 0 NR NR NR 9 NR NR NR 11 
Patton, 2015 USA 1995-2012 60.6 61.5 2.6* 0 NR NR NR 13 NR NR NR 8 
Implantation of antibiotic-loaded cement spacer 




7 patients with spacer 
insitu had no or 
occasional mild pain 
7 patients had spacer 
insitu at final follow-up 





































Myerson, 2014 USA 2002-2011 65.1% 100 1.1 0 2 NR NR 7 NR NR NR 10 
Patton, 2015 USA 1995-2012 65 100 4.6* 0 NR NR NR 1 NR NR NR 8 
Arthrodesis 
Kotnis, 2006 UK 1999-2004 52.0 0.0 NR 0 NR NA NR 1 NR NR NR 9 
Kessler, 2014 Switzerland 2006-2011 62.1* 14.0* 2.6* 0 NR NA NR 3 None of the 3 
patients had 
intact function 
NR NR 11 
Myerson, 2014 USA 2002-2011 63.7 50.0 2.2* 3 NR NA 3 6 NR NR NR 10 
Patton, 2015 USA 1995-2012 50.3 33.3 4.6* 0 NR NA NR 3 NR NR NR 8 
 
*, for all participants; AOFAS, American Orthopaedic Foot and Ankle Society score; DAIR, debridement and implant retention; FAOS, Foot and Ankle Outcomes Score; Short Form–36; SMFA, Short Musculoskeletal 
Function Assessment; NA, not applicable; NR, not reported; TAR, total ankle replacement 
 
 
